HEPATITIS C

This study is testing a hepatitis C medication (glecaprevir/pibrentasvir) in 30 pregnant women who have hepatitis C, with or without HIV. The goal is to see if the drug is safe and works well during pregnancy, potentially curing the mother and preventing the baby from getting the…

This study compares a new oral medication, Bemnifosbuvir-Ruzasvir, to the current standard treatment, Sofosbuvir-Velpatasvir, for adults with chronic hepatitis C. About 880 participants who have not taken similar drugs before will receive one of the two treatments. The main goal …

This study looks at whether starting hepatitis C treatment during pregnancy works well for women who have used drugs. About 50 pregnant women will take the medication glecaprevir-pibrentasvir and be followed for a year. Researchers will check how well they stick to the treatment …

This study looks at whether it is safe to use hearts from donors who have hepatitis C for heart transplants. Researchers will track 500 people who receive these hearts to see how well they do, including survival, rejection, and cure rates for hepatitis C. The goal is to expand th…

This study is testing whether a dried blood spot test can effectively screen for hepatitis B, hepatitis C, and AIDS in people who use drugs. The goal is to make testing easier and more accessible for this group. About 500 current or former drug users will take part.

This study collects DNA samples from 1200 adults receiving routine care at the University of Chicago. Researchers test for genetic differences that could affect how patients respond to certain medications, including risk of side effects. The results are shared with their doctors,…

This study looks at medical records from 15,000 people with chronic liver diseases (like hepatitis, fatty liver, or cirrhosis) to understand how these conditions affect other body systems. Researchers will track new cases of liver cancer and serious liver complications over time.…

This study is testing whether a quick finger-stick test can help find more people with hepatitis C and connect them to treatment. Researchers will offer the test to 60,000 people at high risk, such as those visiting drug treatment clinics or prisons. Participants take a single te…

This study follows people with or at risk for liver diseases (like hepatitis B, C, D) to learn how these conditions develop and progress. Participants give blood and urine samples, get yearly liver ultrasounds, and may have optional biopsies. The goal is to gather information, no…

This study tests a smartphone app designed to teach emergency room patients about hepatitis C (HCV). The app provides personalized information about liver health, HCV knowledge, and steps to get care. Researchers want to see if using the app helps patients understand their condit…